Mold exposure affects people differently — some individuals develop acute allergic reactions after brief exposure; others live for years in moldy homes before noticing symptoms; a subset of genetically susceptible individuals develops a persistent inflammatory condition that can be disabling. Understanding where on this spectrum your symptoms fall is the first step toward getting appropriate care and, critically, addressing the mold source itself.

This guide covers the full spectrum of mold health effects: the biological mechanisms, the diagnostic landscape (including which tests have solid evidence behind them and which are controversial), treatment approaches, and the particular risks mold poses to children.

How Mold Affects the Human Body

Mold produces health effects through three primary exposure pathways:

Inhalation (Primary Route)

Airborne mold spores — typically 2–10 microns in diameter — are inhaled and deposit in the upper and lower respiratory tract. Spores from Stachybotrys chartarum (black mold), Aspergillus, Penicillium, and Cladosporium trigger IgE-mediated allergic responses in sensitized individuals. Mycotoxins — secondary metabolites produced by certain mold species — are also aerosolized on spore surfaces and fine dust particles and can reach the lower lung and, in some models, cross epithelial barriers. Inhalation is the most clinically significant exposure pathway in indoor environments.

Ingestion

Ingestion of mycotoxin-contaminated food (primarily grains, nuts, dried fruits, and spices) is a significant public health issue in agricultural settings, but is less relevant in the context of indoor building mold. Mycotoxin contamination of water-damaged food items can occur but is rarely a primary exposure route in residential mold situations.

Skin Contact

Direct skin contact with mold can trigger contact dermatitis in sensitized individuals. Dermal absorption of mycotoxins is possible in laboratory settings but its contribution to systemic illness from indoor mold exposure is not well-established in the scientific literature.

Who Is Most Vulnerable?

The populations most at risk for significant health effects from indoor mold exposure include: infants and young children (whose immune systems are still developing), the elderly, individuals with asthma or pre-existing allergic conditions, immunocompromised individuals (HIV/AIDS, chemotherapy patients, organ transplant recipients), and those with certain HLA-DR gene variants associated with impaired mycotoxin clearance.

The Spectrum of Mold Health Effects

Common Symptoms of Mold Exposure

Mold exposure can affect virtually every organ system, which is one reason it is frequently misdiagnosed or attributed to other conditions. Below is a system-by-system breakdown of reported and documented symptoms:

Respiratory System

• Nasal and sinus congestion; runny nose; postnasal drip
• Sneezing and itching of the nose, throat, and palate
• Cough (often dry and persistent)
• Wheezing, shortness of breath, chest tightness
• Recurrent sinusitis or upper respiratory infections
• Worsening of pre-existing asthma

Neurological and Cognitive

• "Brain fog" — difficulty concentrating, word-finding problems, slowed processing
• Memory impairment (particularly short-term memory)
• Headaches (often described as pressure-type or migraines)
• Dizziness, disorientation, vertigo
• Peripheral neuropathy (tingling, numbness) — reported in chronic exposure cases
• Mood changes: irritability, anxiety, depression

Skin

• Rashes, hives, or eczema flares
• Unusual skin sensitivity or crawling sensations
• Contact dermatitis from direct mold exposure

Gastrointestinal

• Nausea, abdominal cramping
• Diarrhea or irregular bowel function
• Appetite changes and unexplained weight loss or gain

Immune and Systemic

• Fatigue disproportionate to activity — one of the most universally reported symptoms
• Joint pain and muscle aches without structural cause
• Low-grade fever or temperature dysregulation
• Increased frequency of infections (immune suppression in high mycotoxin exposure)
• Sensitivity to light, sound, or smell

Symptom Severity Escalation: Early Warning to Severe Chronic Illness

For people experiencing severe or chronic symptoms, our resources on black mold (Stachybotrys) health effects and mycotoxins explained provide deeper background on the more serious end of the spectrum.

Mold Illness vs Allergies vs Other Conditions: How to Tell the Difference

Chronic Inflammatory Response Syndrome (CIRS): The Controversial Diagnosis

CIRS, sometimes called "mold illness" in lay circles, is a multi-system illness hypothesis developed primarily by Dr. Ritchie Shoemaker, a Maryland physician who began studying biotoxin-related illness in the late 1990s. The core claim: approximately 24% of the population carries HLA-DR gene variants that impair the innate immune system's ability to clear biotoxins (including mycotoxins). These individuals, when chronically exposed to water-damaged buildings, develop a persistent inflammatory cascade that does not resolve even after mold source removal without specific treatment.

The Shoemaker Protocol

Shoemaker's published diagnostic framework uses a combination of the Visual Contrast Sensitivity (VCS) test, HLA-DR genotyping, and a panel of inflammatory biomarkers including TGF-β1, MMP-9, complement fragments (C4a, C3a), VEGF, and MSH. Proponents argue this represents an objective, measurable basis for diagnosis.

Mainstream Medicine's Position

Mainstream medical organizations — including the American College of Occupational and Environmental Medicine (ACOEM) and the American Academy of Allergy, Asthma & Immunology (AAAAI) — have not formally recognized CIRS as a distinct diagnosis. They note that many of the biomarkers used are non-specific (elevated in many inflammatory conditions), that published CIRS research lacks large-scale randomized controlled trials, and that the VCS test has not been validated specifically for mold illness diagnosis.

The debate is not fully resolved: significant patient communities report meaningful clinical improvement following CIRS-protocol treatment, and several researchers continue investigating biotoxin-related mechanisms. Patients who have been dismissed by conventional medicine and find relief through CIRS-aware practitioners often become strong advocates. Those considering this diagnostic path should work with physicians who are transparent about the evidence base and can rule out other explanations for their symptoms.

Getting a Diagnosis: Which Tests Actually Help

Not all mold-related health testing is equal. Here is an evidence-quality assessment of commonly used tests:

Allergy Skin Prick Testing and Serum IgE (Solid Evidence)

The gold standard for diagnosing IgE-mediated mold allergy. Tests for specific IgE antibodies to common indoor mold species (Aspergillus, Cladosporium, Alternaria, Penicillium). Results are highly reproducible and clinically actionable. If your primary concern is allergic asthma or allergic rhinitis, this is the starting point. See our mold allergy guide for more.

Pulmonary Function Testing / Spirometry (Solid Evidence)

Essential if mold-related asthma or hypersensitivity pneumonitis is suspected. Objective measurement of airflow obstruction and lung capacity.

HLA-DR Genotyping (Moderate Evidence / Investigational)

HLA-DR genotyping identifies genetic variants associated with impaired biotoxin clearance in the Shoemaker CIRS model. The test itself is technically accurate; however, its interpretation as predictive of CIRS risk is not validated by large independent studies. Useful as one component of a workup in the right clinical context.

Mycotoxin Urine Testing (Low to Controversial Evidence)

Several commercial laboratories offer urine mycotoxin panels claiming to measure trichothecenes, ochratoxin, and other mycotoxins. The clinical evidence supporting these tests as diagnostic tools for mold-related illness is currently weak: reference ranges for "normal" mycotoxin excretion are not well-established, lab methodologies vary significantly, and detectable urinary mycotoxins can result from dietary exposure rather than inhalation. These tests may have research value but should not be the primary basis for clinical decisions.

Visual Contrast Sensitivity (VCS) Test (Investigational)

An online or in-office test measuring the ability to distinguish contrast gradients, proposed by Shoemaker as an objective CIRS screening tool. Positive VCS findings are non-specific and can result from many neurological or ophthalmological conditions. Use cautiously as a screening adjunct only.

Treatment Approaches for Mold Illness

Regardless of the specific mold-related diagnosis, source removal is the primary treatment. No medical treatment is effective if ongoing mold exposure continues. This is the one point of agreement between mainstream medicine and functional medicine practitioners in this field. If you need help arranging a professional mold inspection, call (332) 220-0303 — free consultations available 24/7.

Source Removal

Professional mold remediation of water-damaged buildings — done correctly with post-remediation verification — is the foundational intervention. See our mold remediation process guide and our resource on mold air sampling to understand what clearance testing involves.

Nasal Rinse and Intranasal Corticosteroids (Mainstream — Strong Evidence)

Daily saline nasal irrigation (neti pot or squeeze bottle) reduces fungal biofilm burden in the sinuses and is a low-risk, evidence-backed intervention for mold-related rhinosinusitis. Intranasal corticosteroids (fluticasone, mometasone) reduce inflammation in allergic rhinitis with a strong evidence base.

Antifungals for Fungal Sinusitis (Mainstream — Moderate Evidence)

In cases of confirmed fungal sinusitis (eosinophilic fungal rhinosinusitis or invasive fungal sinusitis), antifungal therapy (itraconazole, amphotericin B in invasive cases) is indicated. This is distinct from sensitivity to environmental mold — fungal sinusitis involves actual fungal colonization of sinus tissue.

Cholestyramine and Binders (CIRS Protocol — Limited Evidence)

Cholestyramine (a bile acid sequestrant) is used in the Shoemaker CIRS protocol as a mycotoxin binder — the hypothesis being that it interrupts enterohepatic recirculation of biotoxins. Some CIRS practitioners also use activated charcoal, bentonite clay, or modified citrus pectin as alternatives. Controlled evidence for these as mold illness treatments is limited; they are generally low-risk but should be supervised by a physician as cholestyramine has significant drug interactions.

VIP (Vasoactive Intestinal Peptide) Nasal Spray (CIRS Protocol — Investigational)

A late-stage CIRS protocol intervention used to normalize neuropeptide levels. Not FDA-approved for this indication; available through compounding pharmacies. Use only under physician supervision after completing earlier protocol steps.

Children and Mold: Symptoms to Watch For

Children are more vulnerable to mold's health effects than adults for several biological reasons: higher respiratory rate relative to body size (greater inhaled dose per unit time), smaller airways (greater obstruction from inflammation), immature immune and neurological systems still in critical developmental periods, and longer time spent in the home environment.

The 2004 Institute of Medicine (now National Academy of Medicine) report — one of the most comprehensive scientific reviews of the field — found sufficient evidence to conclude that exposure to indoor mold in damp buildings was associated with upper respiratory tract symptoms, cough, wheeze, and asthma symptoms in otherwise healthy children. Evidence was suggestive for associations with lower respiratory illness in young children.

Symptoms Specific to Children

• Recurrent respiratory infections: Frequent colds, ear infections, and bronchitis that do not resolve normally
• New-onset or worsening asthma: Mold is one of the strongest known triggers for pediatric asthma development and exacerbation. See our mold and asthma guide.
• Behavioral changes: Irritability, emotional dysregulation, and increased oppositional behavior have been reported anecdotally in children with chronic mold exposure; the mechanistic basis is not fully established but neuroinflammatory pathways are proposed.
• Academic performance decline: Cognitive symptoms including attention problems, processing speed slowdowns, and memory difficulties can present as declining school performance. These are often attributed to other causes before mold exposure is considered.
• Growth and developmental concerns: Chronic inflammation from any cause can suppress growth hormone signaling and immune development. Extended mold illness in children warrants pediatric specialist evaluation.

Pregnant women represent another high-risk group — see our dedicated resource on mold exposure during pregnancy for specific guidance.

Frequently Asked Questions: Mold Illness Symptoms